​

Tvardi Therapeutics Ownership | Who Owns Tvardi Therapeutics?

OverviewChart

Tvardi Therapeutics Ownership Summary

Tvardi Therapeutics is owned by 9.60% institutional investors, 27.53% insiders, and 62.87% retail investors. Slate path capital lp is the largest institutional shareholder, holding 8.54% of TVRD shares.

TVRD Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTvardi Therapeutics9.60%27.53%62.87%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Slate path capital lp704.12K8.54%$27.44M
Vanguard group419.17K5.08%$16.33M
Blackrock funding, inc. /de329.91K4.00%$12.86M
683 capital management176.03K2.13%$6.77M
Vestal point capital, lp167.00K2.03%$6.51M
Geode capital management147.92K1.79%$5.77M
Invesco82.61K1.00%$3.22M
Fmr82.22K1.00%$3.20M
Parkman healthcare partners65.00K0.79%$2.53M
State street62.86K0.76%$2.45M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Slate path capital lp704.12K0.42%$27.44M
683 capital management176.03K0.35%$6.77M
Vestal point capital, lp167.00K0.29%$6.51M
Parkman healthcare partners65.00K0.26%$2.53M
Monaco asset management sam13.59K0.03%$529.60K
Diadema partners lp2.19K0.02%$85.15K
Persistent asset partners500.000.01%$19.48K
Boothbay fund management20.19K0.01%$786.76K
Farallon capital management43.23K0.01%$1.68M
Silvercrest asset management group22.37K0.01%$871.60K

Top Buyers

HolderShares% AssetsChange
Vestal point capital, lp167.00K0.29%167.00K
Invesco82.61K0.00%82.61K
Fmr82.22K0.00%82.22K
Parkman healthcare partners65.00K0.26%65.00K
Blackrock funding, inc. /de329.91K0.00%62.04K

Top Sellers

HolderShares% AssetsChange
Marshall wace, llp---24.98K
Headlands---3.43K
Morgan stanley3.79K--1.11K
Citigroup72.00--1.08K
Renaissance30.18K0.00%-1.06K

New Positions

HolderShares% AssetsChangeValue
Vestal point capital, lp167.00K0.29%167.00K$6.51M
Invesco82.61K0.00%82.61K$3.22M
Parkman healthcare partners65.00K0.26%65.00K$2.53M
Goldman sachs group24.03K0.00%24.03K$936.41K
Silvercrest asset management group22.37K0.01%22.37K$871.60K

Sold Out

HolderChange
Sound income strategies-2.00
Trust co of toledo na /oh/-9.00
Kiker wealth management-13.00
Raymond james financial-65.00
Headlands-3.43K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202530-897,987-9-30---

Insider Transactions Trends

DateBuySell
2025 Q2--

TVRD Ownership FAQ

Who Owns Tvardi Therapeutics?

Tvardi Therapeutics shareholders are primarily institutional investors at 9.60%, followed by 27.53% insiders and 62.87% retail investors. The average institutional ownership in Tvardi Therapeutics's industry, Biotech Stocks , is 295.31%, which Tvardi Therapeutics falls below.

Who owns the most shares of Tvardi Therapeutics?

Tvardi Therapeutics’s largest shareholders are Slate path capital lp (704.12K shares, 8.54%), Vanguard group (419.17K shares, 5.08%), and Blackrock funding, inc. /de (329.91K shares, 4.00%). Together, they hold 17.62% of Tvardi Therapeutics’s total shares outstanding.

Does Blackrock own Tvardi Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Tvardi Therapeutics.

Who is Tvardi Therapeutics’s biggest shareholder by percentage of total assets invested?

Slate path capital lp is Tvardi Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.42% of its assets in 704.12K Tvardi Therapeutics shares, valued at 27.44M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools